These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25678454)

  • 1. Transfusion-Related Acute Lung Injury After IVIG for Myasthenic Crisis.
    Reddy DR; Guru PK; Blessing MM; Stubbs JR; Rabinstein AA; Wijdicks EF
    Neurocrit Care; 2015 Oct; 23(2):259-61. PubMed ID: 25678454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related acute lung injury after transfusion of pooled immune globulin: a case report.
    Quest GR; Gaal H; Clarke G; Nahirniak S
    Transfusion; 2014 Dec; 54(12):3088-91. PubMed ID: 24898568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: acute renal failure after administering intravenous immunoglobulin.
    Graumann A; Zawada ET
    Postgrad Med; 2010 Mar; 122(2):142-7. PubMed ID: 20203465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report.
    Yanagihashi M; Okamoto R; Morioka H; Sawada M; Matsumoto S; Ikeda T; Kano O
    BMC Neurol; 2020 Aug; 20(1):319. PubMed ID: 32859168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyshidrotic eczema associated with the use of IVIg.
    Kotan D; Erdem T; Acar BA; Boluk A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.
    Bourque PR; Pringle CE; Cameron W; Cowan J; Chardon JW
    PLoS One; 2016; 11(8):e0159993. PubMed ID: 27490101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient.
    Stoclin A; Delbos F; Dauriat G; Brugière O; Boeri N; Métivier AC; Thabut G; Camus P; Mal H
    Vox Sang; 2013 Feb; 104(2):175-8. PubMed ID: 22985417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenic crisis after a renal transplant successfully treated with intravenous immunoglobulin.
    Hwang IH; Lee KN; Kim IY; Lee DW; Lee SB; Kim DS; Song SH; Seong EY; Kwak IS
    Exp Clin Transplant; 2014 Dec; 12(6):555-8. PubMed ID: 24568644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
    Pittayanon R; Treeprasertsuk S; Phanthumchinda K
    J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
    Ferrero B; Durelli L
    Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-related acute lung injury (TRALI) after intravenous immunoglobulins: French multicentre study and literature review.
    Baudel JL; Vigneron C; Pras-Landre V; Joffre J; Marjot F; Ait-Oufella H; Bigé N; Maury E; Guidet B; Fain O; Mekinian A
    Clin Rheumatol; 2020 Feb; 39(2):541-546. PubMed ID: 31760541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy for neuromuscular disorders.
    Ross MA
    Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
    Mullane D; Williams L; Merwick A; Tobin WO; McGuigan C
    Ir Med J; 2012 Jun; 105(6):182-3. PubMed ID: 22973657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin as treatment for myasthenia gravis: current evidence and outcomes.
    Alabdali M; Barnett C; Katzberg H; Breiner A; Bril V
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1659-65. PubMed ID: 25331319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
    Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
    Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in intravenous immunoglobulin G regimens for autoimmune neuromuscular disorders.
    Broyles R; Rodden L; Riley P; Berger M
    Postgrad Med; 2013 Mar; 125(2):65-72. PubMed ID: 23816772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.